{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:32:24Z","timestamp":1785407544405,"version":"3.56.0"},"reference-count":29,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S1047951126113286_as1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sirolimus is increasingly used for symptomatic or large cardiac rhabdomyoma, but the risk of recurrence remain unclear. We evaluated clinical response, tumour regression, recurrence, and safety in infants treated with sirolimus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951126113286_as2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This retrospective study included all infants with symptomatic or large cardiac rhabdomyoma treated with sirolimus between January 2022 and June 2025. Sirolimus was initiated at 1 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      \/day and titrated to maintain trough levels of 5\u201315 ng\/mL. Serial echocardiography and electrocardiography monitored obstruction, cardiac function, arrhythmias, and tumour regression or recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951126113286_as3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      For the 11 infants included, sirolimus was initiated at a mean age of 19.4 \u00b1 8.9 days. Indications overlapped and included heart failure (\n                      <jats:italic>n<\/jats:italic>\n                      = 5), ventricular outflow tract obstruction (\n                      <jats:italic>n<\/jats:italic>\n                      = 4), clinically significant arrhythmias (\n                      <jats:italic>n<\/jats:italic>\n                      = 4), and the presence of a large tumour (\n                      <jats:italic>n<\/jats:italic>\n                      = 7). TSC1\/TSC2 mutations were identified in 5 infants, and another 5 had extracardiac features of tuberous sclerosis complex. The mean tumour size reduced by 32% at 1 month and 77% at final follow-up, with complete disappearance in 64%. Arrhythmias resolved except in one infant with persistent congenital complete heart block present at baseline. The mean time to achieve a complete clinical response was 19.3 \u00b1 3.98 days of sirolimus therapy. The mean duration of sirolimus therapy was 215 \u00b1 103 days with a maximum of 385 days. Mild hypertriglyceridaemia (\n                      <jats:italic>n<\/jats:italic>\n                      = 2) was the only adverse effect, but it did not warrant discontinuation of sirolimus therapy. Three (27%) infants had tumour regrowth after treatment cessation; all responded promptly to re-initiation of sirolimus.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1047951126113286_as4\">\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Sirolimus is a safe and effective for symptomatic cardiac rhabdomyoma in infants, producing rapid clinical stabilisation and tumour regression. The optimal duration of therapy is uncertain, and the risk of tumour regrowth after cessation warrants longer follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s1047951126113286","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:02:21Z","timestamp":1779800541000},"page":"990-996","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Sirolimus for symptomatic cardiac rhabdomyoma in infants: outcomes, recurrence, and safety"],"prefix":"10.1017","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-1323","authenticated-orcid":false,"given":"Ankur","family":"Handa","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dwcqs71","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9172-938X","authenticated-orcid":false,"given":"Swaminathan","family":"Krishnaswamy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dwcqs71","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3993-0718","authenticated-orcid":false,"given":"Nabeel Valappil","family":"Faisal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dwcqs71","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamk","family":"Kadiyani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dwcqs71","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasubramanian","family":"Ramakrishnan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dwcqs71","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Jagia","sequence":"additional","affiliation":[{"name":"Cardiovascular Radiology and Endovascular Interventions at All India Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3267-1899","authenticated-orcid":false,"given":"Saurabh Kumar","family":"Gupta","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02dwcqs71","id-type":"ROR","asserted-by":"publisher"}],"name":"All India Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"S1047951126113286_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.005"},{"key":"S1047951126113286_ref22","first-page":"447","article-title":"Evaluation of sirolimus dosing in neonates and infants with lymphatic disorders: a case series","volume":"27","author":"Serio","year":"2022","journal-title":"J Pediatr Pharmacol Ther JPPT"},{"key":"S1047951126113286_ref23","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951120003819"},{"key":"S1047951126113286_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2013.12.018"},{"key":"S1047951126113286_ref24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2000.00443.x"},{"key":"S1047951126113286_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-024-03420-0"},{"key":"S1047951126113286_ref10","doi-asserted-by":"publisher","DOI":"10.2350\/06-11-0191.1"},{"key":"S1047951126113286_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.02.040"},{"key":"S1047951126113286_ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000490662"},{"key":"S1047951126113286_ref28","first-page":"361","article-title":"Sirolimus-induced regression of tuberous sclerosis-associated cardiac rhabdomyoma causing left ventricular outflow tract obstruction","volume":"6","author":"Winkie","year":"2022","journal-title":"CASE Phila Pa"},{"key":"S1047951126113286_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244915"},{"key":"S1047951126113286_ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63508"},{"key":"S1047951126113286_ref14","doi-asserted-by":"publisher","DOI":"10.1017\/S104795111700244X"},{"key":"S1047951126113286_ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000460813"},{"key":"S1047951126113286_ref8","first-page":"111","article-title":"Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"S1047951126113286_ref11","first-page":"424","article-title":"[Rapamycin in the treatment of cardiac rhabdomyoma associated with tuberous sclerosis complex]","volume":"54","author":"Pang","year":"2016","journal-title":"Zhonghua Er Ke Za Zhi Chin J Pediatr"},{"key":"S1047951126113286_ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jes029"},{"key":"S1047951126113286_ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100391"},{"key":"S1047951126113286_ref19","first-page":"258","article-title":"Rapid regression of prenatally identified intrapericardial giant rhabdomyomas with sirolimus","volume":"2","author":"Patel","year":"2018","journal-title":"CASE Cardiovasc Imaging Case Rep"},{"key":"S1047951126113286_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2021.07.013"},{"key":"S1047951126113286_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.06.109"},{"key":"S1047951126113286_ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158476"},{"key":"S1047951126113286_ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1386089"},{"key":"S1047951126113286_ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094907"},{"key":"S1047951126113286_ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2033"},{"key":"S1047951126113286_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2018.e00070"},{"key":"S1047951126113286_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2019.07.030"},{"key":"S1047951126113286_ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ped4.12397"},{"key":"S1047951126113286_ref1","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00250-6"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951126113286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:35:25Z","timestamp":1782128125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951126113286\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1047951126113286"],"URL":"https:\/\/doi.org\/10.1017\/s1047951126113286","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}